David Hojnacki is a Neurology physician affiliated with Jacobs Institute. OpenAlex indexes 137 publications with 4,329 citations (h-index 35).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
28 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
60%Human Immunoglobulin G60%Immune globulin100%Part B, office-administered≥11 patientsNervous system
17.8%Gabapentinoids3.9%Gabapentin100%Part D≥34 patientsPotassium Channel Blocker2.9%Dalfampridine Er91%Ampyra9%Part D<11 patients+ 15 more classes in this area
Cancer & immunology
11.6%Interferon beta5.4%Avonex Pen77%Avonex18%Plegridy Pen5%Part D<11 patientsOther immunostimulants4%Copaxone66%Glatiramer Acetate34%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Leptomeningeal, dura mater and meningeal vessel wall enhancements in multiple sclerosis
Multiple Sclerosis and Related Disorders
2020 - Disability Improvement Is Associated with Less Brain Atrophy Development in Multiple Sclerosis
American Journal of Neuroradiology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Lipshultz, MD
Jacobs Institute
Amit Kandel, MBBS
Jacobs Institute
Drucy Borowitz, MD
Jacobs Institute
Rabi Yacoub, MD
Jacobs Institute
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”